Guido Sauter
HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44 Natural Killer Cells in Ulcerative Colitis.
Baumdick M, Niehrs A, Degenhardt F, Schwerk M, Hinrichs O, Jordan-Paiz A, Padoan B, Wegner L, Schloer S, Zecher B, Malsy J, Joshi V, Illig C, Schröder-Schwarz J, Möller K, Hamburg Intestinal Tissue Study Group, Martin M, Yuki Y, Ozawa M, Sauter J, Schmidt A, Perez D, Giannou A, Carrington M, Davis R, Schumacher U, Sauter G, Huber S, Puelles V, Melling N, Klein-Franke A, International Inflammatory Bowel Disease Genetics Consortium, Altfeld M, Bunders M, Brand S. HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44 Natural Killer Cells in Ulcerative Colitis. Gastroenterology 2023; 165:946-962.e13.
15.07.2023HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44 Natural Killer Cells in Ulcerative Colitis.
15.07.2023Gastroenterology 2023; 165:946-962.e13
Baumdick Martin E, Niehrs Annika, Degenhardt Frauke, Schwerk Maria, Hinrichs Ole, Jordan-Paiz Ana, Padoan Benedetta, Wegner Lucy H M, Schloer Sebastian, Zecher Britta F, Malsy Jakob, Joshi Vinita R, Illig Christin, Schröder-Schwarz Jennifer, Möller Kimberly J, Hamburg Intestinal Tissue Study Group, Martin Maureen P, Yuki Yuko, Ozawa Mikki, Sauter Jürgen, Schmidt Alexander, Perez Daniel, Giannou Anastasios D, Carrington Mary, Davis Randall S, Schumacher Udo, Sauter Guido, Huber Samuel, Puelles Victor G, Melling Nathaniel, Klein-Franke Andreas, International Inflammatory Bowel Disease Genetics Consortium, Altfeld Marcus, Bunders Madeleine J, Brand Stephan
Presence of bone marrow micro-metastases in stage I-III colon cancer patients is associated with worse disease-free and overall survival
Viehl C, Oertli D, Sauter G, Terracciano L, Langer I, Banz V, Ramser M, Rosenthal R, Dell-Kuster S, Gueller U, Weixler B, Zuber M. Presence of bone marrow micro-metastases in stage I-III colon cancer patients is associated with worse disease-free and overall survival. Cancer Med 2017; 6:918-927.
12.04.2017Presence of bone marrow micro-metastases in stage I-III colon cancer patients is associated with worse disease-free and overall survival
12.04.2017Cancer Med 2017; 6:918-927
Viehl Carsten T, Oertli Daniel, Sauter Guido, Terracciano Luigi, Langer Igor, Banz Vanessa, Ramser Michaela, Rosenthal Rachel, Dell-Kuster Salome, Gueller Ulrich, Weixler Benjamin, Zuber Markus
Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma
Bolli M, Sauter G, Heberer M, Harder F, Gambazzi F, Mirlacher M, Haas P, Dalquen P, Guller U, Adamina M, Kocher T, Spagnoli G. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma. Ann Surg 2002; 236:785-93; discussion 793.
01.12.2002Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma
01.12.2002Ann Surg 2002; 236:785-93; discussion 793
Bolli Martin, Sauter Guido, Heberer Michael, Harder Felix, Gambazzi Franco, Mirlacher Martina, Haas Philippe, Dalquen Peter, Guller Ulrich, Adamina Michel, Kocher Thomas, Spagnoli Giulio C